ERBB2 and triple-negative breast carcinoma: A higher incidence of triple-negative breast cancer (TNBC) was observed in the diabetic group compared to the nondiabetic group (20.3% vs. 15.2%; p = 0.039), while the HER2-positive rate was lower (8.7% vs. 12.8%; p = 0.043).